An Evening With the Experts: Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Download All
Hear from the experts on how the latest clinical data inform the use of biomarkers to assess risk and selection of CDK4/6 inhibitor–based therapy for patients with HR+/HER2- early breast cancer in these downloadable slides and on-demand webcast from a live CCO webinar.
Sara Hurvitz, MD, FACP
Joyce O'Shaughnessy, MD
Sara Tolaney, MD, MPH

On-Demand Webcast

Learn from the experts how to assess recurrence risk, incorporate CDK4/6 inhibitor–based therapy, and manage treatment-related adverse events for patients with HR+/HER2- early breast cancer in this on-demand webcast from a live webinar.

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Sara Tolaney, MD, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: July 9, 2021 Expired: July 8, 2022

Downloadable Slidesets

Learn how experts leverage the latest data and clinical tools to estimate prognosis and predict treatment benefit in patients with HR-positive, HER2-negative early breast cancer.

Joyce O'Shaughnessy, MD Released: June 15, 2021

Get up to date on how to optimally integrate CDK4/6 inhibitors into adjuvant therapy for patients with HR-positive, HER2-negative early breast cancer, from individualizing treatment selection to managing adverse events.

Sara Tolaney, MD, MPH Released: June 16, 2021

Review the latest developments in leveraging CDK4/6 inhibitors in the neoadjuvant setting for patients with HR-positive, HER2-negative early breast cancer.

Sara Hurvitz, MD, FACP Released: June 15, 2021

Download this short slideset featuring key expert insights on current optimal management of patients with HR-positive, HER2-negative early breast cancer.

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Sara Tolaney, MD, MPH Released: June 18, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Lilly

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue